Walleye Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.5K Sell
132
-13,605
-99% -$6.85M ﹤0.01% 3834
2025
Q4
$6.41M Buy
+13,737
New +$6.38M 0.02% 963
2025
Q3
Sell
-6,393
Closed -$2.48M 4751
2025
Q2
$2.45M Buy
6,393
+1,377
+27% +$496K 0.01% 1359
2025
Q1
$1.73M Buy
5,016
+3,859
+334% +$1.24M 0.01% 1522
2024
Q4
$347K Sell
1,157
-7,531
-87% -$2.63M ﹤0.01% 3301
2024
Q3
$3.53M Buy
8,688
+6,862
+376% +$2.51M 0.01% 1443
2024
Q2
$587K Buy
1,826
+1,360
+292% +$442K ﹤0.01% 3378
2024
Q1
$155K Buy
+466
New +$142K ﹤0.01% 4134
2023
Q4
Sell
-12,464
Closed -$3.08M 5178
2023
Q3
$3.07M Buy
12,464
+3,966
+47% +$1.09M 0.01% 1393
2023
Q2
$2.58M Buy
8,498
+7,926
+1,386% +$2.2M 0.01% 1163
2023
Q1
$151K Buy
+572
New +$145K ﹤0.01% 2681
2018
Q3
$961K Buy
+6,908
New +$860K 0.45% 67

Other funds holding HCA

Walleye Capital's HCA Position: Q1 2026 in Review

Walleye Capital reduced its HCA Healthcare (HCA) stake by 99% in Q1 2026, selling an estimated $6.85M and leaving 132 shares worth $62.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3834.

Walleye Capital first reported a position in HCA in Q3 2018 and has held it in 12 quarters since. The position peaked at $6.41M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Walleye Capital held 132 shares of HCA Healthcare worth $62.5K as of Q1 2026.
  • Walleye Capital sold 13,605 HCA Healthcare shares in Q1 2026, an estimated $6.85M.
  • HCA Healthcare made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3834 holding.
  • Walleye Capital first reported a position in HCA Healthcare in Q3 2018 and has held it in 12 quarters since.
  • Walleye Capital's HCA Healthcare position peaked at $6.41M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.